Friday, March 24, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Featured News

Stony Brook University Selected for BARDA-DRIVe Program

by Global Biodefense Staff
June 11, 2018
BARDA DRIVe - Transforming Health Security

Credit: HHS

Stony Brook University has been selected as one of eight institutions charged by the Department of Health and Human Services (HHS) with accelerating solutions to combat health security threats.

Through the federal BARDA-DRIVe program, the Center for Biotechnology will receive financial resources to support the incubation of businesses that can innovate in the detection and treatment of sepsis.

Sepsis is a top cause of hospitalization in America, leads to 250,000 deaths annually and costs approximately $24 billion a year to treat, according to HHS. The number of sepsis cases could skyrocket after a bioterrorism attack or pandemic.

Stony Brook’s proposal is aimed at mining the robust academic portfolio of biomedical research within metropolitan New York, according to Clinton Rubin, SUNY Distinguished Professor in the Department of Biomedical Engineering in the College of Engineering and Applied Sciences.

DRIVe is a transformative, business-friendly approach to accelerating lifesaving innovation to solve tough health challenges that span health security and daily healthcare. DRIVe is named after the office that oversees it, the Division of Research, Innovation, and Ventures, part of the Biomedical Advanced Research and Development Authority (BARDA) within the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services.

The accelerator network assists individual innovators, startups and other businesses in developing their technologies and products, connecting innovators with essential product development and business support services. This support could position innovative technologies and products for follow-on investment from the public or private sectors.

Sources: Stony Brook University, PHE.gov

Tags: ASPRBARDAHHSSepsis

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions
Pathogens

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
The device appears smaller than a playing card, transparent, with visible channels branching off.
Medical Countermeasures

How Organ-on-a-chip Models Could Grease the Drug Development Pipeline

January 10, 2023
Load More

Latest News

Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are okay with it.OkPrivacy policy